BRCA2 and neoplasm: We have demonstrated that compared to primary chemoresistant HGSOC, LT survival in HGSOC can be characterized by elevated mutation burden, biallelic inactivation of BRCA1 or BRCA2, and increased CD4+ and CD8+ lymphocytic infiltration in the tumor microenvironment.